Wang Liu
-
- Cancer, Lipids, and Metabolism 4
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
-
- Cancer-related Molecular Pathways 2
-
- RNA modifications and cancer 4
-
- Ferroptosis and cancer prognosis 8
-
- Obstructive Sleep Apnea Research 2
-
- Traditional Chinese Medicine Analysis 2
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Frontiers in Oncology (2 papers)BioMed Research International (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wang Liu
28 papers receiving 278 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 64
- Oncology 76
- Immunology 47
- Molecular Biology 141
- Pulmonary and Respiratory Medicine 62
Countries citing papers authored by Wang Liu
This map shows the geographic impact of Wang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Liu more than expected).
Fields of papers citing papers by Wang Liu
This network shows the impact of papers produced by Wang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Liu. The network helps show where Wang Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 34 | |
| 12 | 2021 | 21 | |
| 13 | 2020 | 6 | |
| 14 | 2019 | 52 | |
| 15 | 2019 | 8 | |
| 16 | 2018 | 2 | |
| 17 | High-level sports teams in universities and colleges in China Current Situation and Development Strategies | 2011 | 0 |
| 18 | 2011 | 62 | |
| 19 | 2010 | 2 | |
| 20 | Clinical Observation on the Treatment of Pyelonephritis with Cefoperazone Sulbactam | 2009 | 1 |
About Wang Liu
Wang Liu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Endocrine and Autonomic Systems, having authored 29 papers that have together received 282 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (8 papers), Cancer, Lipids, and Metabolism (4 papers), RNA modifications and cancer (4 papers), Obstructive Sleep Apnea Research (2 papers), MicroRNA in disease regulation (2 papers), Traditional Chinese Medicine Analysis (2 papers), Cancer-related Molecular Pathways (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (64 citations), Oncology (76 citations) and Immunology (47 citations). Wang Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chia‐Yang Liu, Xia Hou, Benyi Li, Yu Zeng, Jian Huang, Sahar Shekoohi, Xiuping Yu, Mingyi Li, Shu Yang and Dhaval S. Patel. Their work appears in journals such as Frontiers in Oncology, BioMed Research International, Frontiers in Pharmacology, Clinica Chimica Acta and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.